Zybev 100 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Zybev 100 mg Injection

Zybev 100 mg Injection

Zybev 100 mg Injection contains bevacizumab, a monoclonal antibody used in the treatment of several types of cancer. It is supplied as a 100 mg/4 mL injection and is administered by intravenous infusion under medical supervision. Bevacizumab blocks VEGF, helping reduce the formation of blood vessels that supply growing tumors.

BUY NOW

Category

Zybev 100 mg Injection is used in combination with other anticancer treatments for conditions including metastatic colorectal cancer, non-small cell lung cancer, renal cell carcinoma, cervical cancer, and certain ovarian cancers. Bevacizumab works by targeting vascular endothelial growth factor, a protein that promotes new blood-vessel formation around tumors. By inhibiting this pathway, the medicine can restrict the blood supply needed for tumor growth and progression. Treatment is given according to the prescribed oncology protocol, with monitoring for infusion reactions, blood pressure changes, bleeding, and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Concentration 100 mg/4 mL
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Manufacturer/Marketer Zydus Cadila

Product Also Known As

Zybev 100 mg Injection, Zybev 100 Injection, Zybev Bevacizumab Injection, Bevacizumab 100 mg Injection, Bevacizumab 100 mg/4 mL Injection, Bevacizumab Cancer Injection